Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

21f571ee39132e9aaba.kosf1GmQgS229lipWGC7ZFR9xVP2bawD4M-En1C7YHM.yu9nl1u942LMhAfbbVLeEWwLtyuuVe1ZpvrJ1zbkOEHf2l6gGdTAFYGfAQ~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +92.93%
+14.2%
+7.17%
+10.48%
+38.11%
+46.5%
+9.89%
-16.13%
+3%
+7.81%
Average +21.40%
Weighted average by Cap. +16.36%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
16.86CNY
Average target price
32.43CNY
Spread / Average Target
+92.30%
High Price Target
32.43CNY
Spread / Highest target
+92.30%
Low Price Target
32.43CNY
Spread / Lowest Target
+92.30%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
16.86CNY
Average target price
32.43CNY
Spread / Average Target
+92.30%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc